{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:44:06Z","timestamp":1788929046862,"version":"build-2803163510"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,22]]},"DOI":"10.7759\/cureus.49248","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T16:39:05Z","timestamp":1700671145000},"source":"Crossref","is-referenced-by-count":7,"title":["A Case of Tizanidine Withdrawal Syndrome: Features and Management in the Emergency Department"],"prefix":"10.7759","author":[{"given":"Marwa","family":"Morgom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa M","family":"Sabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Elbashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amal","family":"Alamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Abuazab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadir","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1254\/jjp.59.457","article-title":"Tizanidine may discriminate between imidazoline-receptors and alpha 2-adrenoceptors","volume":"59","author":"Muramatsu I","year":"1992","unstructured":"Muramatsu I, Kigoshi S. Tizanidine may discriminate between imidazoline-receptors and alpha 2-adrenoceptors. Jpn J Pharmacol. 1992, 59:457-9. 10.1254\/jjp.59.457","journal-title":"Jpn J Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.fp0050520","article-title":"Involvement of supraspinal imidazoline receptors and descending monoaminergic pathways in tizanidine-induced inhibition of rat spinal reflexes","volume":"99","author":"Kino Y","year":"2005","unstructured":"Kino Y, Tanabe M, Honda M, Ono H. Involvement of supraspinal imidazoline receptors and descending monoaminergic pathways in tizanidine-induced inhibition of rat spinal reflexes. J Pharmacol Sci. 2005, 99:52-60. 10.1254\/jphs.fp0050520","journal-title":"J Pharmacol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0014-2999(02)01664-3","article-title":"Involvement of imidazoline receptors in the centrally acting muscle-relaxant effects of tizanidine","volume":"445","author":"Honda M","year":"2002","unstructured":"Honda M, Sekiguchi Y, Sato N, Ono H. Involvement of imidazoline receptors in the centrally acting muscle-relaxant effects of tizanidine. Eur J Pharmacol. 2002, 445:187-93. 10.1016\/s0014-2999(02)01664-3","journal-title":"Eur J Pharmacol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/1179547618758022","article-title":"Management of tizanidine withdrawal syndrome: a case report","volume":"11","author":"Su\u00e1rez-Lled\u00f3 A","year":"2018","unstructured":"Su\u00e1rez-Lled\u00f3 A, Padull\u00e9s A, Lozano T, Cobo-Sacrist\u00e1n S, Colls M, J\u00f3dar R. Management of tizanidine withdrawal syndrome: a case report. Clin Med Insights Case Rep. 2018, 11:1179547618758022. 10.1177\/1179547618758022","journal-title":"Clin Med Insights Case Rep"},{"key":"ref5","article-title":"Tizanidine","author":"Ghanavatian S","year":"2022","unstructured":"Ghanavatian S, Derian A. Tizanidine. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2022."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-014-0430-3","article-title":"Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?","volume":"10","author":"Albertson TE","year":"2014","unstructured":"Albertson TE, Chenoweth J, Ford J, Owen K, Sutter ME. Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?. J Med Toxicol. 2014, 10:369-81. 10.1007\/s13181-014-0430-3","journal-title":"J Med Toxicol"},{"key":"ref7","article-title":"","author":"Ahmed SM","year":"2022","unstructured":"Ahmed SM, Ibrahim EA, Elgassim M, Jamil A, Salem W, Elgassim M. Tizanidine; the lethal withdrawal [Conference Abstact]. Emergency Medicine Trainees' Association, Royal College of Emergency Medicine, Blackpool, UK; 2022. https:\/\/www.researchgate.net\/publication\/372910111_Tizanidine_The_Lethal_Withdrawal."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1185\/030079908x261113","article-title":"A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury","volume":"24","author":"Kamen L","year":"2008","unstructured":"Kamen L, Henney HR 3rd, Runyan JD. A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury. Curr Med Res Opin. 2008, 24:425-39. 10.1185\/030079908x261113","journal-title":"Curr Med Res Opin"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2010.10.003","article-title":"A case of delirium, motor disturbances, and autonomic dysfunction due to baclofen and tizanidine withdrawal: a review of the literature","volume":"33","author":"Karol DE","year":"2011","unstructured":"Karol DE, Muzyk AJ, Preud'homme XA. A case of delirium, motor disturbances, and autonomic dysfunction due to baclofen and tizanidine withdrawal: a review of the literature. Gen Hosp Psychiatry. 2011, 33:84.e1-2. 10.1016\/j.genhosppsych.2010.10.003","journal-title":"Gen Hosp Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14659891.2020.1738574","article-title":"Using clonidine in the treatment of tizanidine abuse and withdrawal: a case report of a patient with somatoform","volume":"25","author":"Kitta A","year":"2020","unstructured":"Kitta A, Wippel A, Richwien P, et al.. Using clonidine in the treatment of tizanidine abuse and withdrawal: a case report of a patient with somatoform. J Subst Use. 2020, 25:535-7. 10.1080\/14659891.2020.1738574","journal-title":"J Subst Use"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/205268-a-case-of-tizanidine-withdrawal-syndrome-features-and-management-in-the-emergency-department","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:53Z","timestamp":1707508373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/205268-a-case-of-tizanidine-withdrawal-syndrome-features-and-management-in-the-emergency-department"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.49248","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}